Contact Next Edge Capital
1 Toronto Street, Suite 200
Toronto, ON M5C 2V6
We continue our focus on investing in biotech with Eden Rahim, Portfolio Manager and Options Strategist, Next Edge Capital. While acknowledging the risks involved in biotech, Rahim says the sector...
Valeant’s 20-day ratio of volume traded in Call options to Put options has fallen from a very optimistic 1.4X in mid-December to a more pessimistic 0.6X currently. ...